We are live on
!
Find out more
BPC
Banque Pictet & Cie Portfolio holdings
AUM
$14.2B
1-Year Est. Return
20.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.07%
1 Year Est. Return
+20.68%
3 Year Est. Return
+60.16%
5 Year Est. Return
+100.72%
10 Year Est. Return
+397.78%
AUM
$4B
AUM Growth
+$341M
(+9.3%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
502
New
78
Increased
165
Reduced
119
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$33.7M |
| 2 |
American Express
AXP
|
+$22.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$19.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$17.3M |
| 5 |
Abbott
ABT
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$115M |
| 2 |
General Motors
GM
|
+$25.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$24M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.4M |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.63% |
| 2 | Consumer Discretionary | 11.72% |
| 3 | Consumer Staples | 10.11% |
| 4 | Technology | 9.51% |
| 5 | Energy | 9.26% |
Similar funds
SSA
FGP
BIP
ETC
BBVA
IFP
X
CM
Banque Pictet & Cie's Q2 2014 Portfolio in Review
As of Q2 2014, Banque Pictet & Cie held 502 positions worth $4B, up 9.3% from $3.66B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Banque Pictet & Cie's Q2 2014 filing shows 78 new, 165 increased, 119 reduced and 42 closed positions. Its largest new stake was Thermo Fisher Scientific: 147,040 shares worth $17.4M. The largest sale was Allergan Inc, an estimated $115M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Banque Pictet & Cie's largest Q2 2014 buy was Thermo Fisher Scientific: 147,040 shares worth $17.4M.
- Banque Pictet & Cie added most to Starbucks in Q2 2014, an estimated $33.7M increase.
- Banque Pictet & Cie's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $115M.
- Banque Pictet & Cie fully exited iShares S&P Mid-Cap 400 Growth ETF in Q2 2014, selling an estimated $10.4M.
- Banque Pictet & Cie's ten largest holdings make up 33% of its $4B portfolio in Q2 2014.
- Banque Pictet & Cie opened 78 new positions and closed 42 in Q2 2014.
- Banque Pictet & Cie's portfolio value rose 9.3% quarter-over-quarter to $4B.
Based on Banque Pictet & Cie's 13F filing for Q2 2014, filed 6 Aug 2014.